Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 35 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 9708267

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  2. US 9707230

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  3. US 9707287

    Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  4. US 9707220

    Scopolamine for the treatment of depression and anxiety

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  5. US 9701718

    Adenovirus serotype 26 and serotype 35 filovirus vaccines

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  6. US 9700562

    Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  7. US 9695230

    Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted

  8. US 9688739

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted

  9. US 9683263

    Detection and treatment of irritable bowel syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  10. US 9683269

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  11. US 9676771

    Compounds for inhibiting drug-resistant strains of HIV-1 integrase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  12. US 9676857

    Soluble engineered monomeric Fc

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  13. US 9676788

    Aza-epoxy-guaiane derivatives and treatment of cancer

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  14. US 9676846

    Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  15. US 9670549

    Gene expression signatures of neoplasm responsiveness to therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

  16. US 9663521

    Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 30, 2017 · Expires May 25, 2037

    granted

  17. US 9663485

    Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 30, 2017 · Expires May 25, 2037

    granted

  18. US 9657066

    Pseudomonas exotoxin A with less immunogenic B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted

  19. US 9657292

    Compositions and methods for treating or preventing lupus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted

  20. US 9655366

    Volatile blends and the effects thereof on the navel orangeworm moth

    The United States of America, as represented by the Secretary of Agriculture · Granted May 23, 2017 · Expires May 18, 2037

    granted

  21. US 9657269

    Regulatory B cells (tBREGS) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted

  22. US 9657096

    Human domain antibodies against components of the human insulin-like growth factor (IGF) system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted

  23. US 9649339

    LAT adapter molecule for enhanced T-cell signaling and method of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 16, 2017 · Expires May 11, 2037

    granted

  24. US 9650352

    Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 16, 2017 · Expires May 11, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.